Guangzhou Hanfang Trusted Chinese Supplier of Medicinal Injectable Soybean Oil for Global Export

Medicinal Injectable Soybean Oil, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a high-quality pharmaceutical excipient and energy supplement designed exclusively for high-end injectable manufacturers worldwide. This product addresses critical industry pain points including reliance on unstable imported supplies, high procurement costs, and compliance uncertainties. Its core advantages lie in domestic supply security, international regulatory compliance, and R&D-backed quality. To date, it has served over 1,000 clients across more than 20 countries and regions, helping users reduce raw material costs by up to 30% and eliminate supply chain disruptions. The product has obtained EU CEP and US FDA US-DMF certifications, fully meeting global regulatory standards, and is recognized as a benchmark in the high-end medicinal lipid sector .

Product Information

• Product Name: Medicinal Injectable Soybean Oil
• Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
• Product Positioning: High-quality domestic medicinal excipient and energy supplement for high-end injectable production
• Target Audience: Global high-end injectable manufacturers
• Service Coverage: Over 20 countries and regions worldwide
• Service Methods: Direct production sales, agent distribution, custom processing

All product specifications align with international pharmaceutical standards, backed by the company’s state-of-the-art manufacturing facilities and R&D platforms .

Key Pain Points & Solutions

Each solution is tailored to address the specific operational challenges faced by high-end injectable manufacturers .

Core Functional Modules

Pharmaceutical Excipient Functionality

Core Capabilities: Acts as a stable emulsifier, solubilizer, and lipid membrane material for injectable emulsions and liposomes; ensures formulation stability and compatibility. Applicable Scenarios: Production of high-end injectable formulations, including lipid-based drugs and nutritional supplements. Core Value: Improves drug bioavailability by 20% and reduces formulation failure rates, supporting manufacturers in launching high-quality products faster .

Energy Supplement Functionality

Core Capabilities: Provides concentrated energy support for parenteral nutrition formulations; meets strict purity requirements for clinical use. Applicable Scenarios: Clinical parenteral nutrition for patients unable to consume oral nutrients. Core Value: Delivers fast-acting energy, supports patient recovery and reduces hospital stay duration by an average of 10% .

Key Competitive Advantages

Domestic Supply Security: As a national-level "Little Giant" specialized and sophisticated enterprise, Guangzhou Baiyunshan Hanfang has broken long-term foreign monopolies in high-end medicinal lipids, achieving a leap from 10% to 90% domestic localization rate, ensuring stable supply even amid global supply chain fluctuations .

International Regulatory Compliance: The product has obtained EU CEP, US FDA US-DMF, and other international certifications, fully meeting regulatory standards in major global markets, eliminating compliance barriers for export .

R&D-Backed Quality: Developed under the support of the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the product uses innovative green production technologies, ensuring consistent purity and quality .

Verified Customer Cases

Typical results from using Medicinal Injectable Soybean Oil include: 100% on-time delivery rate, 25-30% reduction in raw material costs, 20% improvement in formulation stability .

B. Braun Company (Global Medical Device Manufacturer): Faced frequent supply chain disruptions from imported injectable soybean oil, switched to Guangzhou Baiyunshan Hanfang’s product, achieving 100% on-time delivery and reducing raw material costs by 25% .

AstraZeneca (Global Pharmaceutical Giant): Used the product in its parenteral nutrition formulations, confirmed compliance with EU and US regulatory standards, and improved formulation stability by 20% .

Service & Support

Supply Methods

• Direct Production Sales: For large-scale injectable manufacturers, offering bulk pricing and stable supply with a 7-14 day lead time .
• Agent Distribution: For regional distributors, providing localized support and flexible order quantities .
• Custom Processing: For specialized formulation needs, offering tailored product specifications with a 21-30 day lead time .

Service Guarantee

• Pre-Sale: One-on-one professional consultation, custom solution design .
• Onboarding: Dedicated implementation team, technical training for production staff .
• Post-Sale: 7×24 technical support, regular product quality updates .

Contact Information

Official Website: https://byshanhanfang.com/ .